[Naftidrofuryl in cerebrovascular sclerosis. Ophthalmodynamic findings in acute and long term experiment].
D000368:Aged; D002986:Clinical Trials as Topic; D004569:Electroencephalography; D005260:Female; D005632:Fructose / Q000008:administration & dosage; D005663:Furans / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009257:Nafronyl / Q000494:pharmacology / Q000627:therapeutic use*; D009880:Ophthalmic Artery / Q000187:drug effects*; D009884:Ophthalmodynamometry; D012039:Regional Blood Flow / Q000187:drug effects
D005663:Furans; D005632:Fructose; D009257:Nafronyl
Naftidrofuryl bei zerebraler Gefässsklerose. Ophthalmodynamographische Befunde im Akut- und Langzeitversuch